Cargando…
RICTOR Affects Melanoma Tumorigenesis and Its Resistance to Targeted Therapy
The network defined by phosphatidylinositol-3-kinase (PI3K), AKT, and mammalian target of rapamycin (mTOR) plays a major role in melanoma oncogenesis and has been implicated in BRAF inhibitor resistance. The central role of RICTOR (rapamycin-insensitive companion of mTOR) in this pathway has only re...
Autores principales: | Jebali, Ahlem, Battistella, Maxime, Lebbé, Céleste, Dumaz, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533235/ https://www.ncbi.nlm.nih.gov/pubmed/34680615 http://dx.doi.org/10.3390/biomedicines9101498 |
Ejemplares similares
-
The role of RICTOR downstream of receptor tyrosine kinase in cancers
por: Jebali, Ahlem, et al.
Publicado: (2018) -
FGF2 Induces Resistance to Nilotinib through MAPK Pathway Activation in KIT Mutated Melanoma
por: Tétu, Pauline, et al.
Publicado: (2020) -
RICTOR involvement in the PI3K/AKT pathway regulation in melanocytes and melanoma
por: Laugier, Florence, et al.
Publicado: (2015) -
Atypical BRAF and NRAS Mutations in Mucosal Melanoma
por: Dumaz, Nicolas, et al.
Publicado: (2019) -
Unmasking the tumourigenic role of SIN1/MAPKAP1 in the mTOR complex 2
por: Ezine, Emilien, et al.
Publicado: (2023)